1. An oral pharmaceutical composition comprising a combination of a diuretic and ACE inhibitor, characterized in that said active substances are micronised forme.2. An oral pharmaceutical composition according to claim 1, characterized in that the micronized form of active components has an average particle size of less than 50 mkm.3. An oral pharmaceutical composition according to claim 1, characterized in that the micronized form of active components has a surface area of at least 20 · 10cm / mg.4. An oral pharmaceutical composition according to any one of claims 1-3, characterized in that the ACE inhibitor is selected from the group consisting of ramipril, enalapril, perindopril, lisinopril, fozinoprila.5. An oral pharmaceutical composition according to any one of claims 1-3, characterized in that the diuretic is selected from the group consisting of indapamide, chlorothiazide, methyclothiazide, bendroflumethiazide, chlorthalidone, metolazone and gidrohlortiazida.6. The medicament hypotensive effect comprising an oral pharmaceutical composition according to any one of claims 1-3, characterized in that it comprises as active ingredients ramipril and indapamide and optionally pharmaceutically acceptable auxiliary substances, mg: 7. The medicament hypotensive effect comprising an oral pharmaceutical composition according to claim 6, characterized in that it comprises as active ingredients ramipril and indapamide and as auxiliary substances lactose monohydrate, colloidal silicon dioxide (Aerosil) stearat.8 calcium. The medicament hypotensive effect comprising an oral pharmaceutical composition according to any one of claims 11. Пероральная фармацевтическая композиция, содержащая комбинацию диуретика и ингибитора АПФ, отличающаяся тем, что указанные активные вещества находятся в микронизированной форме.2. Пероральная фармацевтическая композиция по п.1, отличающаяся тем, что микронизированная форма активных компонентов имеет средний размер частиц менее 50 мкм.3. Перо
